Mark Elliott Boulding - Mar 10, 2025 Form 4 Insider Report for PTC THERAPEUTICS, INC. (PTCT)

Role
EXEC. VP AND CLO
Signature
/s/ Avraham S. Adler, Attorney-in-Fact
Stock symbol
PTCT
Transactions as of
Mar 10, 2025
Transactions value $
-$1,595,392
Form type
4
Date filed
3/12/2025, 05:20 PM
Previous filing
Feb 21, 2025
Next filing
Mar 14, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PTCT Common Stock Options Exercise $1.5M +45.4K +43.69% $33.02 149K Mar 10, 2025 Direct F1
transaction PTCT Common Stock Sale -$2.41M -45.4K -30.4% $53.15 104K Mar 10, 2025 Direct F1, F2
transaction PTCT Common Stock Options Exercise $376K +11.4K +10.97% $33.02 115K Mar 10, 2025 Direct F1
transaction PTCT Common Stock Sale -$605K -11.4K -9.89% $53.12 104K Mar 10, 2025 Direct F1, F3
transaction PTCT Common Stock Options Exercise $289K +11.2K +10.83% $25.69 115K Mar 10, 2025 Direct F1
transaction PTCT Common Stock Sale -$182K -3.49K -3.03% $52.24 112K Mar 10, 2025 Direct F1, F4
transaction PTCT Common Stock Sale -$412K -7.76K -6.95% $53.05 104K Mar 10, 2025 Direct F1, F5
transaction PTCT Common Stock Options Exercise $187K +5.66K +5.45% $33.02 110K Mar 11, 2025 Direct F1
transaction PTCT Common Stock Sale -$300K -5.66K -5.17% $53.02 104K Mar 11, 2025 Direct F1, F6
transaction PTCT Common Stock Options Exercise $56.8K +1.72K +1.65% $33.02 106K Mar 11, 2025 Direct F1
transaction PTCT Common Stock Sale -$91.1K -1.72K -1.63% $53.01 104K Mar 11, 2025 Direct F1, F7

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PTCT Stock Option (Right to Buy) Options Exercise $0 -45.4K -70.73% $0.00 18.8K Mar 10, 2025 Common Stock 45.4K $33.02 Direct F1, F8
transaction PTCT Stock Option (Right to Buy) Options Exercise $0 -11.4K -73.48% $0.00 4.11K Mar 10, 2025 Common Stock 11.4K $33.02 Direct F1, F8
transaction PTCT Stock Option (Right to Buy) Options Exercise $0 -11.2K -25% $0.00 33.8K Mar 10, 2025 Common Stock 11.2K $25.69 Direct F1, F9
transaction PTCT Stock Option (Right to Buy) Options Exercise $0 -5.66K -30.14% $0.00 13.1K Mar 11, 2025 Common Stock 5.66K $33.02 Direct F1, F8
transaction PTCT Stock Option (Right to Buy) Options Exercise $0 -1.72K -41.78% $0.00 2.4K Mar 11, 2025 Common Stock 1.72K $33.02 Direct F1, F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on December 5, 2024.
F2 This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $53.00 to $53.82 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
F3 This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $53.00 to $53.57 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
F4 This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $51.73 to $52.71 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
F5 This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $52.74 to $53.57 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
F6 This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $53.00 to $53.14 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
F7 This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $37.30 to $38.20 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
F8 Currently exercisable.
F9 This option was granted on February 15, 2024, and vests over four years, with 25% of the shares underlying the option vesting on February 15, 2025, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on May 15, 2025.